This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 Strong Stocks to Buy Ahead of 2021 That Don't Need Vaccine Help
by Benjamin Rains
It might be prudent to find firms that were already growing and won't need a vaccine for help. Today, we explore three highly-ranked Zacks stocks that fit the bill...
Buy Soaring Chewy Stock Before Q3 Earnings as E-Commerce Play?
by Benjamin Rains
Chewy (CHWY) is an e-commerce pet store that has expanded into telehealth and bolstered its pet medication offerings...
Zoom's (ZM) Q3 Earnings Top Estimates, Revenues Jump Y/Y
by Zacks Equity Research
Zoom's (ZM) third-quarter fiscal 2021 results reflect solid user growth, driven by coronavirus-led remote-working and Internet-education wave.
Buy Zoom Video (ZM) Stock on the Dip Before Q3 Earnings?
by Benjamin Rains
Let's decide if investors should consider buying the video conferencing stock on the dip despite positive news on the vaccine front...
Should You Invest in the First Trust Consumer Discretionary AlphaDEX ETF (FXD)?
by Zacks Equity Research
Sector ETF report for FXD
3 Cheap Stocks Under $20 to Buy for the Holiday Season and Beyond
by Benjamin Rains
Today we dive into three highly-ranked stocks that are all trading for under $20 per share that appear worth considering now...
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Peloton Interactive, AMC Entertainment and Etsy
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Peloton Interactive, AMC Entertainment and Etsy
Buy Surging Yeti Stock for Lululemon-Style Growth Potential?
by Benjamin Rains
High-end cooler company Yeti topped our third quarter estimates last week and its growth potential appears strong...
More Foot-Traffic & Less Click-Traffic
by Daniel Laboe
Yesterday's hopeful vaccine news from Pfizer (PFE) and BioNTech (BNTX) has put a light at the end of the tunnel for value investors
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Delta Air Lines, Disney and Peloton Interactive
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Delta Air Lines, Disney and Peloton Interactive